Product Portfolio Gap by Leveraging Established Technology

Tyber Medical was formed to address an industry wide lack of rapid access to FDA cleared orthopedic implants. We understand the product gaps in the orthopedic medical device industry. Tyber Medical designs, manufactures, and ensures regulatory clearance by the FDA and CE Marking for the European Union of devices which fill the void in the portfolio of your company. In addition to US and European regulatory approval, Tyber Medical offers approvals by the Brazilian Health Regulatory Agency (ANVISA), the Therapeutic Goods Act (TGA) in Australia and New Zealand, Canada’s Health Canada agency, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Tyber Medical’s approach to market is to private label these orthopedic implants for your company whose product offerings have gaps in spine, trauma, and extremities devices. We create a supply source for your company of rapid access to country specific regulatory cleared implants.

There are two approaches to obtaining a product for your portfolio — an off-the shelf product and a design specific product where there is a hand-off of your partially designed product to us or Tyber Medical works with your company to design a differentiated product.

Recently, an actual scenario developed where a national orthopedic company experienced a major disruption in their supply chain. In less than four months, Tyber Medical was able to supply fixation implants and instruments to fulfill the gap. Subsequently, the companies formed a partnership and created an integrated pipeline release strategy.

Our experienced team has created complete product portfolios by designing a total package, therefore your company will benefit from the breadth of our resources and products. Your company will have the ability to grow without using your own resources, by leveraging our product development and regulatory expertise, and by partnering with us to create strategic growth opportunities.

Take advantage of these savings, contact us today.